GloPID-R
GloPID-R is a non-profit organization founded in 2013 and headquartered in Berlin, Germany, operating with a small team of 7 employees. Its mission, products, and stakeholder base are not documented in the available input data.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingServices
What GloPID-R does
GloPID-R is a non-profit organization founded in 2013 and headquartered in Berlin, Germany. The firm operates with a minimal staff of 7 employees, reflecting a small secretariat-style organizational structure. Its public-facing web property is maintained at https://www.glopid-r.org/.
The available input data does not characterize GloPID-R's mission, programmatic activities, core products, underlying technology, or target constituencies. No products, services, pricing models, revenue mechanics, customer segments, technology stack, partnerships, awards, or certifications were captured in the source material. The attempted retrieval of the organization's website (http://glopid-r.org/) returned only a bot verification / loading page containing no substantive content, and the firm's legal name, founding date, operating status, and ownership structure are similarly undocumented in the input.
Given the data gap, this description is limited to firmographic facts. A meaningful assessment of GloPID-R's functional role, revenue model, and stakeholder base would require additional primary sources beyond what was provided.
GloPID-R firmographics
Firmographics- Name
- GloPID-R
- Website
- https://glopid-r.org
- Company type
- Private
- Headcount range
- 1–10 employees
- Short description
- GloPID-R is a non-profit organization founded in 2013 and headquartered in Berlin, Germany, operating with a small team of 7 employees. Its mission, products, and stakeholder base are not documented in the available input data.
- Ownership category
- akta.pro rank
GloPID-R business model
Business model- GTM type
- B2B
- Offering type
- Services
GloPID-R product offering
Product offeringCore offering
Unable to determine GloPID-R's core offerings from the provided source material. The only accessible content from the website (http://glopid-r.org/) was a bot verification/loader page containing no substantive information about the organization's activities, products, or services.
Differentiator
Problem solved
Functional benefit
Companies that use GloPID-R
Customer profileIdeal customer profiles1 record
GloPID-R technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
GloPID-R competitors and assessment
Company assessmentBroad incumbents
- Wellcome Trust: Wellcome Trust is a major UK-based research charity funding discovery and applied research in infectious diseases. It is a comparable funder peer whose research-coordination role and global scope overlap with GloPID-R's.
- European Health Emergency Preparedness and Response Authority (HERA): HERA is an EU body established post-COVID to strengthen preparedness and response to health emergencies, including coordinating research and development of medical countermeasures. It is a broader institutional incumbent whose coordination role overlaps GloPID-R's European mandate.
- World Health Organization R&D Blueprint: The WHO R&D Blueprint is a global R&D coordination framework that identifies pathogens of pandemic potential and accelerates research response. It is a broader incumbent that overlaps GloPID-R's mandate on priority-setting and coordinating research preparedness across epidemics.
- Bill & Melinda Gates Foundation: The Gates Foundation is one of the world's largest private funders of global health research, including infectious disease R&D. It is a member-funder peer in GloPID-R's alliance and a benchmark for capital scale in the preparedness-funding ecosystem.
- Chan Zuckerberg Initiative (Biohub Network): CZI funds biomedical research infrastructure and pandemic preparedness through its Biohub Network. It is a peer as a large, mission-driven private funder active in the same infectious-disease preparedness space.
Direct peers
- European & Developing Countries Clinical Trials Partnership (EDCTP): EDCTP is a European-funded partnership that coordinates and funds clinical trial research on infectious diseases in sub-Saharan Africa. It mirrors GloPID-R's role as a multi-funder research coordination entity focused on infectious disease preparedness in low-resource settings.
- Coalition for Epidemic Preparedness Innovations (CEPI): CEPI is a global partnership that coordinates and funds accelerated vaccine development against emerging infectious disease threats. It is the closest direct peer to GloPID-R — both organizations focus on coordinating international research responses to epidemics, with GloPID-R emphasizing funder alignment and CEPI emphasizing vaccine R&D financing.
- Global Antibiotic Research & Development Partnership (GARDP): GARDP is a not-for-profit R&D partnership focused on developing new antibiotic treatments for drug-resistant infections. It shares GloPID-R's public-interest, multi-funder coordination model and global health scope, though concentrated on AMR rather than outbreak preparedness.
- The Pandemic Fund: The Pandemic Fund is a World Bank-hosted financing vehicle that channels grants to low- and middle-income countries for pandemic preparedness. It is a peer in the same funding-and-coordination ecosystem GloPID-R operates in, though with substantially larger capital pools.
Emerging players
- Foundation for Innovative New Diagnostics (FIND): FIND is a non-profit that accelerates development and equitable access to diagnostic tests for infectious diseases. It is a peer in the global health R&D coordination ecosystem with a narrower scope (diagnostics) but comparable multi-funder partnership model.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights4 records
Customer concentration
GloPID-R social profiles
Digital presenceGloPID-R financial estimates
Financial estimateRevenue estimate
Valuation estimate
GloPID-R leadership team
Management profileNumber of profiles
GloPID-R funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GloPID-R M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GloPID-R
What does GloPID-R do?
Unable to determine GloPID-R's core offerings from the provided source material. The only accessible content from the website (http://glopid-r.org/) was a bot verification/loader page containing no substantive information about the organization's activities, products, or services.
When was GloPID-R founded?
GloPID-R was founded in -1. It employs 1 to 10 people.
Who are GloPID-R's main competitors?
Broad incumbents on record are Wellcome Trust, European Health Emergency Preparedness and Response Authority (HERA), World Health Organization R&D Blueprint, Bill & Melinda Gates Foundation and Chan Zuckerberg Initiative (Biohub Network). Direct peers are European & Developing Countries Clinical Trials Partnership (EDCTP), Coalition for Epidemic Preparedness Innovations (CEPI), Global Antibiotic Research & Development Partnership (GARDP) and The Pandemic Fund. Foundation for Innovative New Diagnostics (FIND) is listed as an emerging player.
Does GloPID-R have an API?
No public API is recorded for GloPID-R.